breseq version 0.33.1 revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Predicted mutations | ||||||
---|---|---|---|---|---|---|
evidence | position | mutation | freq | annotation | gene | description |
JC | 9,682 | +AGATGA | 10.8% | coding (2651/2664 nt) | gyrA → | DNA topoisomerase (ATP‑hydrolyzing) subunit A |
RA | 9,710 | T→C | 9.1% | intergenic (+15/+72) | gyrA → / ← nnrD | DNA topoisomerase (ATP‑hydrolyzing) subunit A/possible carbohydrate kinase |
RA | 9,716 | T→C | 8.6% | intergenic (+21/+66) | gyrA → / ← nnrD | DNA topoisomerase (ATP‑hydrolyzing) subunit A/possible carbohydrate kinase |
RA | 9,719 | G→A | 7.2% | intergenic (+24/+63) | gyrA → / ← nnrD | DNA topoisomerase (ATP‑hydrolyzing) subunit A/possible carbohydrate kinase |
RA | 9,725 | G→A | 7.6% | intergenic (+30/+57) | gyrA → / ← nnrD | DNA topoisomerase (ATP‑hydrolyzing) subunit A/possible carbohydrate kinase |
RA | 18,223 | G→A | 7.5% | V278I (GTT→ATT) | USA300HOU_0013 → | possible membrane protein |
RA | 28,711 | T→C | 5.0% | N409N (AAT→AAC) | yycH → | hypothetical protein YycH |
RA | 33,584 | C→T | 5.1% | intergenic (+240/‑128) | sasH → / → orfX | possible 5'‑nucleotidase/hypothetical protein OrfX |
RA | 35,814 | Δ1 bp | 22.1% | intergenic (+45/+63) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
RA | 35,817 | A→T | 22.1% | intergenic (+48/+60) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
RA | 35,850 | C→T | 27.8% | intergenic (+81/+27) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
RA | 35,858 | T→A | 32.0% | intergenic (+89/+19) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
RA | 35,876 | C→T | 43.5% | intergenic (+107/+1) | rlmH → / ← tpn | hypothetical protein/IS431mec transposase |
RA | 35,913 | C→G | 25.3% | S213S (TCG→TCC) | tpn ← | IS431mec transposase |
RA | 35,940 | G→A | 29.7% | R204R (CGC→CGT) | tpn ← | IS431mec transposase |
RA | 35,970 | T→C | 53.8% | E194E (GAA→GAG) | tpn ← | IS431mec transposase |
RA | 35,997 | T→C | 30.0% | T185T (ACA→ACG) | tpn ← | IS431mec transposase |
RA | 36,015 | C→T | 29.0% | R179R (AGG→AGA) | tpn ← | IS431mec transposase |
RA | 36,087 | A→G | 56.7% | C155C (TGT→TGC) | tpn ← | IS431mec transposase |
RA | 36,119 | C→T | 27.6% | V145I (GTA→ATA) | tpn ← | IS431mec transposase |
RA | 36,124 | G→A | 55.3% | A143V (GCT→GTT) | tpn ← | IS431mec transposase |
RA | 36,133 | A→G | 28.3% | V140A (GTA→GCA) | tpn ← | IS431mec transposase |
RA | 36,161 | T→C | 29.4% | I131V (ATT→GTT) | tpn ← | IS431mec transposase |
RA | 36,174 | T→C | 28.9% | K126K (AAA→AAG) | tpn ← | IS431mec transposase |
RA | 36,269 | C→T | 56.9% | A95T (GCA→ACA) | tpn ← | IS431mec transposase |
RA | 36,315 | G→A | 56.6% | Y79Y (TAC→TAT) | tpn ← | IS431mec transposase |
RA | 36,378 | C→T | 82.2% | L58L (TTG→TTA) | tpn ← | IS431mec transposase |
RA | 36,413 | C→T | 49.4% | V47I (GTC→ATC) | tpn ← | IS431mec transposase |
RA | 36,444 | C→T | 38.5% | R36R (AGG→AGA) | tpn ← | IS431mec transposase |
RA | 36,471 | A→G | 20.4% | S27S (AGT→AGC) | tpn ← | IS431mec transposase |
RA | 36,479 | T→C | 8.3% | T25A (ACA→GCA) | tpn ← | IS431mec transposase |
RA | 36,501 | G→A | 5.8% | A17A (GCC→GCT) | tpn ← | IS431mec transposase |
RA | 36,581 | C→T | 20.7% | intergenic (‑30/‑493) | tpn ← / → USA300HOU_0028 | IS431mec transposase/hypothetical protein |
RA | 39,653 | C→A | 7.2% | S494I (AGT→ATT) | mecA ← | penicillin binding protein 2 prime |
RA | 61,741 | C→T | 7.4% | E265K (GAA→AAA) | USA300HOU_0055 ← | integrase |
JC | 62,817 | +TCAATT | 100% | intergenic (+82/+229) | USA300HOU_0056 → / ← speG | hypothetical protein/diamine N‑acetyltransferase |
RA | 70,101 | A→T | 7.0% | I228N (ATT→AAT) | arcB1 ← | ornithine carbamoyltransferase |
RA | 76,180 | C→T | 21.6% | intergenic (+238/‑896) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
RA | 76,185 | G→A | 15.0% | intergenic (+243/‑891) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
RA | 76,265 | C→T | 27.6% | intergenic (+323/‑811) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
RA | 76,295 | T→C | 51.6% | intergenic (+353/‑781) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
RA | 76,322 | G→A | 51.1% | intergenic (+380/‑754) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
RA | 76,353 | G→A | 46.5% | intergenic (+411/‑723) | USA300HOU_0072 → / → USA300HOU_0075 | universal stress protein/lysophospholipase |
RA | 90,248 | Δ1 bp | 6.5% | intergenic (‑1292/+1453) | USA300HOU_0086 ← / ← USA300HOU_0089 | hypothetical protein/hypothetical protein |
RA | 90,249 | Δ1 bp | 6.5% | intergenic (‑1293/+1452) | USA300HOU_0086 ← / ← USA300HOU_0089 | hypothetical protein/hypothetical protein |
RA | 109,522 | G→A | 5.6% | T196T (ACG→ACA) | plc → | phosphatidylinositol diacylglycerol‑lyase |
RA | 109,868 | A→C | 5.3% | T312P (ACG→CCG) | plc → | phosphatidylinositol diacylglycerol‑lyase |
RA | 109,958 | G→A | 5.4% | intergenic (+37/‑184) | plc → / → USA300HOU_0109 | phosphatidylinositol diacylglycerol‑lyase/staphylococcal tandem lipoprotein |
RA | 109,964 | T→A | 6.1% | intergenic (+43/‑178) | plc → / → USA300HOU_0109 | phosphatidylinositol diacylglycerol‑lyase/staphylococcal tandem lipoprotein |
RA | 109,970 | T→C | 5.4% | intergenic (+49/‑172) | plc → / → USA300HOU_0109 | phosphatidylinositol diacylglycerol‑lyase/staphylococcal tandem lipoprotein |
RA | 110,651 | C→T | 15.2% | D170D (GAC→GAT) | USA300HOU_0109 → | staphylococcal tandem lipoprotein |
RA | 110,660 | T→A | 18.8% | I173I (ATT→ATA) | USA300HOU_0109 → | staphylococcal tandem lipoprotein |
RA | 111,512 | A→G | 28.6% | S194S (TCA→TCG) | USA300HOU_0110 → | possible staphylococcal tandem lipoprotein |
RA | 111,516 | C→A | 30.5% | Q196K (CAA→AAA) | USA300HOU_0110 → | possible staphylococcal tandem lipoprotein |
RA | 111,560 | T→C | 9.8% | R210R (CGT→CGC) | USA300HOU_0110 → | possible staphylococcal tandem lipoprotein |
RA | 153,592 | A→G | 5.7% | I399V (ATT→GTT) | USA300HOU_0144 → | MOP superfamily multidrug/oligosaccharidyl‑lipid/polysaccharide flippase transporter |
RA | 153,657 | T→C | 8.0% | A420A (GCT→GCC) | USA300HOU_0144 → | MOP superfamily multidrug/oligosaccharidyl‑lipid/polysaccharide flippase transporter |
RA | 159,006 | G→T | 6.1% | S441I (AGC→ATC) | deoD → | MFS family major facilitator transporter, tetracycline:cation symporter |
RA | 166,060 | C→T | 5.6% | S386S (AGC→AGT) | USA300HOU_0156 → | hypothetical protein |
RA | 178,248 | T→G | 7.8% | Y75D (TAT→GAT) | cap5E → | capsular polysaccharide biosynthesis protein Cap5E |
RA | 181,717 | T→A | 5.7% | G137G (GGT→GGA) | cap5H → | capsular polysaccharide biosynthesis protein Cap5H |
RA | 181,798 | T→G | 6.5% | G164G (GGT→GGG) | cap5H → | capsular polysaccharide biosynthesis protein Cap5H |
RA | 182,889 | C→T | 7.8% | L318L (CTA→TTA) | cap5I → | capsular polysaccharide biosynthesis protein Cap5I |
RA | 184,873 | T→C | 5.2% | Y218Y (TAT→TAC) | cap5K → | capsular polysaccharide synthesis protein Cap5K |
RA | 188,684 | G→A | 5.1% | R182H (CGT→CAT) | cap5O → | capsular polysaccharide biosynthesis protein Cap5O |
RA | 209,797 | T→C | 5.8% | V2069A (GTA→GCA) | USA300HOU_0192 → | non‑ribosomal peptide synthetase |
RA | 211,512 | T→A | 5.0% | intergenic (+70/+258) | USA300HOU_0193 → / ← USA300HOU_0194 | possible holo‑[acyl‑carrier‑protein] synthase/hypothetical membrane protein |
RA | 211,621 | G→A | 6.4% | intergenic (+179/+149) | USA300HOU_0193 → / ← USA300HOU_0194 | possible holo‑[acyl‑carrier‑protein] synthase/hypothetical membrane protein |
RA | 225,063 | T→A | 5.3% | I50I (ATT→ATA) | murQ → | possible sugar phosphate isomerase |
RA | 238,173 | T→C | 6.1% | I58I (ATT→ATC) | USA300HOU_0214 → | oligopeptide ABC superfamily ATP binding cassette transporter, membrane protein |
RA | 239,946 | A→G | 6.3% | H256R (CAT→CGT) | rlp → | RGD domain lipoprotein |
RA | 257,325 | T→A | 6.4% | G16G (GGA→GGT) | USA300HOU_0230 ← | response regulator |
RA | 264,043 | C→T | 6.8% | P86P (CCC→CCT) | glpQ1 → | possible glycerophosphodiester phosphodiesterase |
RA | 313,483 | C→T | 5.2% | L220L (TTG→TTA) | USA300HOU_0279 ← | hypothetical protein |
RA | 321,417 | T→C | 5.0% | N166N (AAT→AAC) | bsh3 → | C59 family penicillin amidase |
RA | 321,451 | A→G | 6.1% | N178D (AAT→GAT) | bsh3 → | C59 family penicillin amidase |
RA | 322,033 | A→G | 5.1% | intergenic (+121/‑187) | bsh3 → / → lytM | C59 family penicillin amidase/M23 family lysostaphin |
RA | 322,347 | A→T | 7.4% | Q43L (CAA→CTA) | lytM → | M23 family lysostaphin |
RA | 323,222 | G→A | 6.5% | intergenic (+34/+18) | lytM → / ← USA300HOU_0290 | M23 family lysostaphin/ABC superfamily ATP binding cassette transporter, ABC protein |
RA | 326,758 | A→T | 5.6% | F277Y (TTT→TAT) | USA300HOU_0293 ← | hypothetical protein |
RA | 329,916 | G→A | 5.2% | L88F (CTT→TTT) | USA300HOU_0296 ← | hypothetical protein |
RA | 340,248 | T→C | 6.2% | N1462N (AAT→AAC) | essC → | virulence protein EssC |
RA | 340,254 | A→G | 5.4% | A1464A (GCA→GCG) | essC → | virulence protein EssC |
RA | 340,266 | A→G | 7.2% | A1468A (GCA→GCG) | essC → | virulence protein EssC |
RA | 340,269 | C→T | 6.3% | N1469N (AAC→AAT) | essC → | virulence protein EssC |
RA | 340,494 | A→G | 5.6% | I55V (ATT→GTT) | esaC → | virulence protein EsaC |
RA | 348,494 | C→T | 5.4% | T144M (ACG→ATG) | USA300HOU_0315 → | hypothetical protein |
RA | 352,072 | A→C | 5.2% | intergenic (+4/‑7) | USA300HOU_0319 → / → USA300HOU_0320 | hypothetical protein/hypothetical protein |
RA | 352,078 | C→T | 5.7% | intergenic (+10/‑1) | USA300HOU_0319 → / → USA300HOU_0320 | hypothetical protein/hypothetical protein |
RA | 352,096 | G→A | 5.7% | K6K (AAG→AAA) | USA300HOU_0320 → | hypothetical protein |
JC | 353,691 | Δ3 bp | 5.7% | intergenic (+127/‑24) | USA300HOU_0322 → / → USA300HOU_0323 | hypothetical protein/hypothetical membrane protein |
RA | 354,925 | A→G | 5.6% | S84S (AGT→AGC) | ywcJ ← | FNT family formate‑nitrite transporter |
RA | 354,940 | A→T | 5.4% | I79I (ATT→ATA) | ywcJ ← | FNT family formate‑nitrite transporter |
RA | 354,943 | G→A | 5.4% | G78G (GGC→GGT) | ywcJ ← | FNT family formate‑nitrite transporter |
RA | 355,168 | A→G | 5.0% | S3S (AGT→AGC) | ywcJ ← | FNT family formate‑nitrite transporter |
RA | 355,263 | C→A | 5.5% | intergenic (‑87/+129) | ywcJ ← / ← brnQ1 | FNT family formate‑nitrite transporter/LIVCS family branched chain amino acid:cation symporter |
RA | 355,692 | G→T | 6.5% | V336V (GTC→GTA) | brnQ1 ← | LIVCS family branched chain amino acid:cation symporter |
RA | 365,528 | C→T | 5.1% | G367D (GGT→GAT) | USA300HOU_0334 ← | SSS family solute:sodium (Na+) symporter |
RA | 373,905 | C→T | 5.1% | D532D (GAC→GAT) | lip1 → | triacylglycerol lipase |
RA | 380,443 | G→A | 5.1% | A113A (GCG→GCA) | lplA1 → | lipoate‑‑protein ligase A |
RA | 392,622 | G→A | 5.7% | A229A (GCG→GCA) | yhbW → | possible alkanal monooxygenase (FMN‑linked) |
RA | 402,652 | T→C | 5.2% | L87L (TTG→CTG) | USA300HOU_0372 → | ABC superfamily ATP binding cassette transporter, ABC protein |
RA | 402,660 | G→A | 5.1% | V89V (GTG→GTA) | USA300HOU_0372 → | ABC superfamily ATP binding cassette transporter, ABC protein |
RA | 409,376 | A→T | 5.8% | A272A (GCT→GCA) | metE ← | 5‑methyltetrahydropteroyltriglutamate‑‑ homocysteine S‑methyltransferase |
RA | 419,854 | G→A | 12.2% | intergenic (+72/+194) | rpsR → / ← USA300HOU_0390 | ribosomal protein S18/hypothetical protein |
RA | 433,119 | T→G | 5.1% | intergenic (‑528/+449) | tcyP ← / ← USA300HOU_0408 | possible DAACS family dicarboxylate/amino acid:sodium (Na+) or proton (H+) symporter/hypothetical protein |
RA | 434,024 | T→A | 5.2% | A167A (GCA→GCT) | USA300HOU_0408 ← | hypothetical protein |
RA | 439,372 | C→T | 6.7% | G374G (GGC→GGT) | guaB → | IMP dehydrogenase |
RA | 453,608 | T→C | 5.9% | L116L (TTA→CTA) | set22 → | staphylococcal exotoxin |
RA | 464,595 | A→G | 6.0% | K91R (AAA→AGA) | USA300HOU_0439 → | hypothetical protein |
RA | 464,599 | G→A | 5.9% | P92P (CCG→CCA) | USA300HOU_0439 → | hypothetical protein |
RA | 475,163 | C→T | 6.1% | D159D (GAC→GAT) | cobW1 → | cobalamin (vitamin B12) biosynthesis protein |
RA | 486,048 | G→A | 5.1% | intergenic (+1426/‑4352) | USA300HOU_0463 → / → metQ | hypothetical protein/ABC superfamily ATP binding cassette transporter, binding protein |
RA | 491,299 | G→T | 7.3% | intergenic (+57/‑275) | metQ → / → sle1 | ABC superfamily ATP binding cassette transporter, binding protein/possible LysM family autolysin |
RA | 491,302 | G→C | 7.8% | intergenic (+60/‑272) | metQ → / → sle1 | ABC superfamily ATP binding cassette transporter, binding protein/possible LysM family autolysin |
RA | 491,332 | T→A | 7.3% | intergenic (+90/‑242) | metQ → / → sle1 | ABC superfamily ATP binding cassette transporter, binding protein/possible LysM family autolysin |
RA | 495,436 | C→T | 5.9% | A228T (GCA→ACA) | yibE ← | hypothetical membrane protein |
RA | 512,643 | A→G | 43.5% | intergenic (+711/‑150) | recR → / → rrs1 | recombination protein RecR/16S ribosomal RNA |
RA | 534,181 | C→G | 6.1% | intergenic (+3752/‑1973) | veg → / → rplY | hypothetical protein/ribosomal protein L25 |
RA | 545,072 | A→T | 5.2% | S131S (TCA→TCT) | yabR → | hypothetical protein |
RA | 584,277 | C→T | 5.8% | Y30Y (TAC→TAT) | rplJ → | ribosomal protein L10 |
RA | 604,295 | T→C | 6.7% | intergenic (+88/‑126) | araB → / → USA300HOU_0546 | ribulokinase/possible UDP‑glucose 4‑epimerase |
RA | 612,852 | A→T | 5.3% | A388A (GCA→GCT) | sdrC → | Ser‑Asp rich fibrinogen/bone sialoprotein‑binding protein SdrC |
RA | 613,998 | G→A | 6.4% | S770S (TCG→TCA) | sdrC → | Ser‑Asp rich fibrinogen/bone sialoprotein‑binding protein SdrC |
RA | 614,094 | T→C | 13.9% | S802S (AGT→AGC) | sdrC → | Ser‑Asp rich fibrinogen/bone sialoprotein‑binding protein SdrC |
RA | 615,441 | C→G | 5.0% | A181A (GCC→GCG) | sdrD → | Ser‑Asp rich fibrinogen/bone sialoprotein‑binding protein SdrD |
RA | 615,494 | A→C | 5.3% | D199A (GAT→GCT) | sdrD → | Ser‑Asp rich fibrinogen/bone sialoprotein‑binding protein SdrD |
RA | 618,351 | T→C | 7.5% | D1151D (GAT→GAC) | sdrD → | Ser‑Asp rich fibrinogen/bone sialoprotein‑binding protein SdrD |
RA | 618,387 | T→C | 8.9% | D1163D (GAT→GAC) | sdrD → | Ser‑Asp rich fibrinogen/bone sialoprotein‑binding protein SdrD |
RA | 618,558 | T→C | 7.3% | S1220S (AGT→AGC) | sdrD → | Ser‑Asp rich fibrinogen/bone sialoprotein‑binding protein SdrD |
RA | 618,756 | T→C | 9.5% | S1286S (AGT→AGC) | sdrD → | Ser‑Asp rich fibrinogen/bone sialoprotein‑binding protein SdrD |
RA | 628,481 | C→A | 5.3% | intergenic (‑154/‑116) | USA300HOU_0562 ← / → nagB | hypothetical protein/glucosamine‑6‑phosphate deaminase |
RA | 631,293 | T→A | 5.2% | G189G (GGT→GGA) | USA300HOU_0566 → | possible phosphatase |
RA | 631,329 | G→A | 5.1% | P201P (CCG→CCA) | USA300HOU_0566 → | possible phosphatase |
RA | 631,338 | T→A | 5.4% | I204I (ATT→ATA) | USA300HOU_0566 → | possible phosphatase |
RA | 631,341 | T→C | 5.4% | I205I (ATT→ATC) | USA300HOU_0566 → | possible phosphatase |
RA | 632,109 | C→G | 6.2% | V78V (GTC→GTG) | proP → | MFS family major facilitator transporter, proline/betaine:cation symporter |
RA | 648,427 | A→T | 5.3% | A90A (GCA→GCT) | mvaD → | diphosphomevalonate decarboxylase |
RA | 668,096 | G→A | 5.2% | A27A (GCG→GCA) | adh → | alcohol dehydrogenase |
RA | 696,863 | T→C | 5.2% | V277V (GTT→GTC) | mnhA1 → | CPA3 family monovalent cation (K+ or Na+):proton (H+) antiporter‑3, MnhA subunit |
RA | 696,902 | T→C | 5.5% | I290I (ATT→ATC) | mnhA1 → | CPA3 family monovalent cation (K+ or Na+):proton (H+) antiporter‑3, MnhA subunit |
RA | 696,932 | T→A | 5.4% | G300G (GGT→GGA) | mnhA1 → | CPA3 family monovalent cation (K+ or Na+):proton (H+) antiporter‑3, MnhA subunit |
RA | 696,941 | G→A | 6.1% | A303A (GCG→GCA) | mnhA1 → | CPA3 family monovalent cation (K+ or Na+):proton (H+) antiporter‑3, MnhA subunit |
RA | 696,944 | C→T | 5.8% | Y304Y (TAC→TAT) | mnhA1 → | CPA3 family monovalent cation (K+ or Na+):proton (H+) antiporter‑3, MnhA subunit |
RA | 696,962 | T→A | 5.2% | L310L (CTT→CTA) | mnhA1 → | CPA3 family monovalent cation (K+ or Na+):proton (H+) antiporter‑3, MnhA subunit |
RA | 707,909 | A→T | 5.1% | M1M (TTG→ATG) † | mntB ← | ABC superfamily ATP binding cassette transporter, ABC protein |
RA | 732,682 | T→C | 6.6% | Y235Y (TAT→TAC) | USA300HOU_0679 → | hypothetical protein |
RA | 736,210 | C→T | 6.8% | T231I (ACA→ATA) | vraE → | ABC superfamily ATP binding cassette transporter, membrane protein |
RA | 748,209 | T→C | 6.3% | A68A (GCT→GCC) | USA300HOU_0694 → | LysR family transcriptional regulator |
RA | 770,883 | T→C | 5.7% | intergenic (+69/‑184) | ebsC → / → fruR | possible transcriptional regulator/DeoR family transcriptional regulator |
RA | 792,603 | C→T | 5.0% | N543N (AAC→AAT) | ltaS → | possible phosphatidylglycerol‑‑membrane‑oligosaccharide glycerophosphotransferase |
RA | 795,968 | C→T | 6.3% | R296R (CGC→CGT) | recQ1 → | ATP‑dependent helicase RecQ |
RA | 803,539 | A→G | 6.7% | intergenic (+47/+31) | USA300HOU_0750 → / ← dtpT | hypothetical protein/POT family proton (H+)‑dependent oligopeptide transporter |
RA | 840,445 | C→G | 5.3% | A226A (GCC→GCG) | uvrA → | excision endonuclease subunit UvrA |
RA | 841,258 | A→G | 6.0% | L497L (TTA→TTG) | uvrA → | excision endonuclease subunit UvrA |
RA | 841,492 | T→G | 7.3% | G575G (GGT→GGG) | uvrA → | excision endonuclease subunit UvrA |
RA | 841,564 | A→C | 7.1% | E599D (GAA→GAC) | uvrA → | excision endonuclease subunit UvrA |
RA | 864,720 | G→A | 5.8% | E12E (GAG→GAA) | est → | carboxylesterase |
RA | 864,726 | T→C | 5.7% | G14G (GGT→GGC) | est → | carboxylesterase |
RA | 864,745 | C→T | 6.9% | L21L (CTA→TTA) | est → | carboxylesterase |
RA | 864,753 | T→A | 5.9% | G23G (GGT→GGA) | est → | carboxylesterase |
RA | 864,777 | T→A | 7.3% | V31V (GTT→GTA) | est → | carboxylesterase |
RA | 864,828 | G→A | 5.7% | P48P (CCG→CCA) | est → | carboxylesterase |
RA | 879,923 | A→G | 5.3% | intergenic (+101/‑240) | USA300HOU_0822 → / → nuc | hypothetical protein/micrococcal nuclease |
RA | 885,761 | T→C | 5.3% | T101A (ACT→GCT) | yisU ← | LysE family L‑lysine exporter |
RA | 888,334 | T→A | 5.5% | V219E (GTA→GAA) | aroD → | 3‑dehydroquinate dehydratase |
RA | 914,471 | G→A | 5.1% | E161E (GAG→GAA) | sufS → | selenocysteine lyase |
RA | 917,327 | T→G | 6.4% | intergenic (+86/‑104) | sufB → / → USA300HOU_0876 | ABC superfamily ATP binding cassette transporter, membrane protein/hypothetical protein |
RA | 922,773 | G→A | 5.9% | E159K (GAA→AAA) | yunD → | bifunctional 5‑nucleotidase/2,3‑cyclic phosphodiesterase |
RA | 922,777 | T→A | 5.8% | L160H (CTT→CAT) | yunD → | bifunctional 5‑nucleotidase/2,3‑cyclic phosphodiesterase |
RA | 922,800 | T→A | 6.0% | L168I (TTA→ATA) | yunD → | bifunctional 5‑nucleotidase/2,3‑cyclic phosphodiesterase |
RA | 937,158 | T→A | 5.3% | intergenic (+65/‑1952) | yumB → / → USA300HOU_0903 | NADH dehydrogenase/NhaC family sodium:proton (Na+:H+) antiporter |
RA | 938,905 | G→A | 6.6% | intergenic (+1812/‑205) | yumB → / → USA300HOU_0903 | NADH dehydrogenase/NhaC family sodium:proton (Na+:H+) antiporter |
RA | 940,348 | T→C | 5.5% | R413R (CGT→CGC) | USA300HOU_0903 → | NhaC family sodium:proton (Na+:H+) antiporter |
RA | 946,579 | A→C | 5.4% | F488L (TTT→TTG) | mnhA2 ← | CPA3 family monovalent cation:proton (H+) antiporter‑3 subunit A |
RA | 950,088 | T→A | 6.7% | intergenic (+875/‑280) | prsA1 → / → yqiG | peptidylprolyl isomerase/flavin reductase |
RA | 950,093 | T→A | 6.8% | intergenic (+880/‑275) | prsA1 → / → yqiG | peptidylprolyl isomerase/flavin reductase |
RA | 950,098 | T→A | 7.4% | intergenic (+885/‑270) | prsA1 → / → yqiG | peptidylprolyl isomerase/flavin reductase |
RA | 967,498 | C→G | 5.3% | V522V (GTC→GTG) | rexA → | ATP‑dependent nuclease Rex subunit A |
RA | 985,066 | T→A | 6.9% | intergenic (‑131/‑164) | USA300HOU_0940 ← / → fabH1 | hypothetical protein/3‑oxoacyl‑[acyl‑carrier‑protein] synthase |
RA | 985,069 | A→T | 7.0% | intergenic (‑134/‑161) | USA300HOU_0940 ← / → fabH1 | hypothetical protein/3‑oxoacyl‑[acyl‑carrier‑protein] synthase |
RA | 1,038,235 | A→T | 5.0% | intergenic (‑4652/‑3054) | USA300HOU_0983 ← / → USA300HOU_0984 | competence protein/glycosyltransferase |
RA | 1,039,416 | A→C | 5.8% | intergenic (‑5833/‑1873) | USA300HOU_0983 ← / → USA300HOU_0984 | competence protein/glycosyltransferase |
RA | 1,039,417 | T→G | 5.9% | intergenic (‑5834/‑1872) | USA300HOU_0983 ← / → USA300HOU_0984 | competence protein/glycosyltransferase |
RA | 1,043,713 | C→T | 6.3% | L8L (CTA→TTA) | USA300HOU_0985 → | possible iron (Fe3+) ABC superfamily ATP binding cassette transporter, binding protein |
RA | 1,049,317 | G→A | 5.9% | A325A (GCG→GCA) | menD → | 2‑oxoglutarate decarboxylase |
RA | 1,049,332 | G→A | 5.9% | R330R (AGG→AGA) | menD → | 2‑oxoglutarate decarboxylase |
RA | 1,052,385 | C→G | 6.0% | A341A (GCG→GCC) | sspB ← | C47 family staphopain B |
RA | 1,052,403 | G→A | 5.5% | D335D (GAC→GAT) | sspB ← | C47 family staphopain B |
RA | 1,052,436 | G→A | 6.1% | I324I (ATC→ATT) | sspB ← | C47 family staphopain B |
RA | 1,072,831 | A→T | 6.2% | G121G (GGT→GGA) | folD ← | bifunctional methylenetetrahydrofolate dehydrogenase (NADP(+))/methenyltetrahydrofolate cyclohydrolase |
RA | 1,088,197 | G→A | 7.1% | intergenic (‑515/‑355) | USA300HOU_1021 ← / → USA300HOU_1022 | hypothetical membrane protein/hypothetical membrane protein |
RA | 1,152,738 | A→T | 5.5% | I329L (ATA→TTA) | dinB → | DNA‑directed DNA polymerase IV beta subunit |
RA | 1,166,243 | A→T | 5.5% | intergenic (‑537/‑135) | USA300HOU_1092 ← / → USA300HOU_1093 | hypothetical protein/hypothetical membrane protein |
RA | 1,172,863 | T→G | 6.3% | N191T (AAC→ACC) | USA300HOU_1103 ← | exotoxin |
RA | 1,182,264 | A→T | 6.3% | intergenic (‑283/‑81) | USA300HOU_t0016 ← / → USA300HOU_1112 | tRNA‑Arg/antibacterial protein |
RA | 1,190,794 | A→G | 8.1% | A167A (GCA→GCG) | mraY → | phospho‑N‑acetylmuramoyl‑pentapeptide‑ transferase |
RA | 1,218,734 | A→C | 6.0% | intergenic (+225/+38) | USA300HOU_1145 → / ← fbpA | possible 3‑demethylubiquinone‑9 3‑methyltransferase/fibrinogen‑binding protein |
RA | 1,231,411 | A→G | 7.0% | D19G (GAT→GGT) | prpC → | possible PP2C protein phosphatase |
RA | 1,231,557 | C→G | 6.3% | Q68E (CAA→GAA) | prpC → | possible PP2C protein phosphatase |
RA | 1,250,301 | C→G | 6.8% | T24R (ACA→AGA) | ftsY → | Sec family Type I general secretory pathway protein signal recognition particle protein FtsY |
RA | 1,272,132 | G→C | 5.0% | intergenic (+28/‑38) | clpQ → / → clpY | T01 family HslV component of HsIUV peptidase/T01 family HslU component of HsIUV peptidase |
RA | 1,299,428 | A→G | 5.6% | K363K (AAA→AAG) | rnjB → | beta‑lactamase |
RA | 1,299,677 | C→T | 7.3% | G446G (GGC→GGT) | rnjB → | beta‑lactamase |
RA | 1,299,755 | T→A | 9.1% | V472V (GTT→GTA) | rnjB → | beta‑lactamase |
RA | 1,306,583 | C→T | 5.4% | P216S (CCA→TCA) | fabG → | short chain dehydrogenase |
RA | 1,306,597 | T→C | 5.9% | S220S (AGT→AGC) | fabG → | short chain dehydrogenase |
RA | 1,315,762 | A→C | 7.9% | A348A (GCA→GCC) | porA → | ferredoxin dehydrogenase alpha subunit |
RA | 1,319,376 | A→G | 7.5% | I504V (ATA→GTA) | miaB → | 2‑methylthioadenine synthetase |
RA | 1,331,236 | T→A | 6.9% | S188T (TCT→ACT) | USA300HOU_1233 → | possible S33 family lysophophospholipase |
RA | 1,338,620 | G→A | 8.2% | S21S (TCG→TCA) | USA300HOU_1241 → | hypothetical protein |
RA | 1,338,681 | A→G | 8.0% | R42G (AGA→GGA) | USA300HOU_1241 → | hypothetical protein |
RA | 1,339,817 | C→A | 13.6% | intergenic (+149/‑145) | USA300HOU_1242 → / → USA300HOU_1243 | hypothetical protein/hypothetical protein |
RA | 1,340,479 | A→T | 6.6% | intergenic (+311/‑390) | USA300HOU_1243 → / → USA300HOU_1244 | hypothetical protein/hypothetical protein |
RA | 1,341,749 | G→T | 5.6% | intergenic (+157/‑355) | USA300HOU_1245 → / → USA300HOU_1246 | hypothetical protein/hypothetical protein |
RA | 1,341,933 | G→A | 6.1% | intergenic (+341/‑171) | USA300HOU_1245 → / → USA300HOU_1246 | hypothetical protein/hypothetical protein |
RA | 1,341,936 | C→A | 6.4% | intergenic (+344/‑168) | USA300HOU_1245 → / → USA300HOU_1246 | hypothetical protein/hypothetical protein |
RA | 1,346,067 | T→C | 6.6% | intergenic (‑211/+259) | USA300HOU_1259 ← / ← ltaE | hypothetical protein/threonine aldolase |
RA | 1,346,086 | C→T | 5.9% | intergenic (‑230/+240) | USA300HOU_1259 ← / ← ltaE | hypothetical protein/threonine aldolase |
RA | 1,346,192 | C→T | 6.5% | intergenic (‑336/+134) | USA300HOU_1259 ← / ← ltaE | hypothetical protein/threonine aldolase |
RA | 1,349,021 | A→T | 6.8% | P382P (CCA→CCT) | cls → | cardiolipin synthetase |
RA | 1,349,027 | A→T | 6.9% | V384V (GTA→GTT) | cls → | cardiolipin synthetase |
RA | 1,353,873 | A→C | 5.8% | intergenic (+66/+77) | nucA → / ← USA300HOU_1269 | micrococcal nuclease A/hypothetical protein |
RA | 1,354,358 | T→C | 5.9% | I149M (ATA→ATG) | USA300HOU_1269 ← | hypothetical protein |
RA | 1,372,042 | A→T | 6.1% | V524V (GTA→GTT) | tkt → | transketolase |
RA | 1,390,631 | T→G | 6.3% | intergenic (+115/+13) | parC → / ← USA300HOU_1289 | DNA topoisomerase (ATP‑hydrolyzing) ParC/hypothetical protein |
RA | 1,411,832 | T→C | 5.4% | H280H (CAT→CAC) | femA → | methicillin resistance factor FemA |
RA | 1,416,458 | A→T | 100% | I216N (ATT→AAT) | oppD ← | oligopeptide ABC superfamily ATP binding cassette transporter, ABC protein |
RA | 1,421,615 | C→G | 5.1% | intergenic (+51/+89) | oppD → / ← phoU | M3 family oligoendopeptidase F/possible PnaS family phosphate:sodium (Na+) symporter |
RA | 1,436,095 | G→C | 6.2% | G197A (GGT→GCT) | hipO → | M20D subfamily hippurate hydrolase |
RA | 1,436,255 | T→A | 6.5% | T250T (ACT→ACA) | hipO → | M20D subfamily hippurate hydrolase |
RA | 1,450,291 | G→A | 8.1% | D273D (GAC→GAT) | odhB ← | dihydrolipoyllysine‑residue succinyltransferase |
RA | 1,451,633 | C→T | 8.2% | A763A (GCG→GCA) | sucA ← | oxoglutarate dehydrogenase (succinyl‑transferring) E1 |
RA | 1,454,646 | T→C | 5.3% | A305A (GCA→GCG) | arlS ← | sensor histidine kinase |
RA | 1,458,321 | T→C | 5.2% | T14A (ACA→GCA) | USA300HOU_1354 ← | phosphatase |
RA | 1,469,100 | G→A | 6.2% | V16V (GTG→GTA) | ypdP → | hypothetical protein |
RA | 1,481,732 | C→T | 6.0% | T6764T (ACG→ACA) | ebh ← | extracellular matrix binding protein |
RA | 1,481,750 | C→T | 5.2% | A6758A (GCG→GCA) | ebh ← | extracellular matrix binding protein |
RA | 1,489,391 | C→T | 7.3% | P4211P (CCG→CCA) | ebh ← | extracellular matrix binding protein |
RA | 1,503,111 | A→G | 7.6% | I234I (ATT→ATC) | norB ← | MFS family major facilitator transporter |
RA | 1,504,140 | T→A | 6.1% | R384R (CGA→CGT) | USA300HOU_1374 ← | APC family amino acid‑polyamine‑organocation transporter |
RA | 1,504,143 | T→C | 6.2% | E383E (GAA→GAG) | USA300HOU_1374 ← | APC family amino acid‑polyamine‑organocation transporter |
RA | 1,509,367 | C→T | 7.1% | E1008K (GAG→AAG) | ypbR ← | hypothetical protein |
RA | 1,512,101 | C→T | 8.6% | T96T (ACG→ACA) | ypbR ← | hypothetical protein |
RA | 1,513,930 | A→T | 100% | L413F (TTA→TTT) | USA300HOU_1379 → | hypothetical membrane protein |
RA | 1,514,978 | T→C | 6.1% | G274G (GGA→GGG) | ypsC ← | site‑specific DNA‑methyltransferase (adenine‑specific) |
RA | 1,517,372 | C→A | 7.8% | D115Y (GAT→TAT) | USA300HOU_1385 ← | hypothetical protein |
RA | 1,521,608 | G→A | 6.6% | intergenic (+548/+18) | pbp2 → / ← USA300HOU_1389 | penicillin‑binding protein 2/hypothetical protein |
RA | 1,526,104 | C→T | 6.5% | S613S (TCG→TCA) | dnaQ ← | DNA‑directed DNA polymerase III epsilon subunit |
RA | 1,538,398 | T→G | 6.1% | G168G (GGA→GGC) | aroC ← | chorismate synthase |
RA | 1,542,361 | C→T | 5.5% | V46V (GTG→GTA) | USA300HOU_1409 ← | hypothetical protein |
RA | 1,615,309 | A→T | 6.4% | intergenic (‑39/+10) | xerD ← / ← fur | integrase/recombinase XerD/Fur family transcriptional regulator |
RA | 1,616,268 | C→A | 5.9% | V50L (GTG→TTG) | nudF ← | ADP‑ribose diphosphatase |
RA | 1,627,378 | G→T | 5.9% | I365I (ATC→ATA) | pgd ← | phosphogluconate dehydrogenase (decarboxylating) |
RA | 1,646,189 | G→C | 100% | A155G (GCA→GGA) | pepP ← | M24B family Xaa‑Pro dipeptidase |
RA | 1,664,318 | T→C | 5.9% | I30V (ATA→GTA) | pbp3 ← | penicillin‑binding protein 3 |
RA | 1,704,548 | A→T | 5.4% | D89E (GAT→GAA) | yqeI ← | hypothetical protein |
RA | 1,708,413 | C→T | 5.9% | T43I (ACA→ATA) | USA300HOU_1602 → | hypothetical membrane protein |
RA | 1,731,859 | A→G | 6.0% | Q20R (CAA→CGA) | yvbT → | dehydrogenase |
RA | 1,735,527 | T→A | 5.1% | A236A (GCA→GCT) | hypB ← | hypothetical protein |
RA | 1,740,388 | G→A | 6.8% | L230L (CTA→TTA) | lytH ← | N‑acetylmuramoyl‑L‑alanine amidase |
RA | 1,746,065 | A→T | 5.6% | V301D (GTC→GAC) | recJ ← | recombination protein RecJ |
RA | 1,749,170 | T→A | 5.1% | V93V (GTA→GTT) | secDF ← | RND superfamily resistance‑nodulation‑cell division protein:proton (H+) antiporter |
RA | 1,789,169 | A→T | 5.6% | V117V (GTT→GTA) | gapB ← | glyceraldehyde‑3‑phosphate dehydrogenase (phosphorylating) |
RA | 1,814,162 | G→A | 6.2% | V360V (GTC→GTT) | dnaE2 ← | DNA‑directed DNA polymerase III alpha subunit |
RA | 1,825,570 | A→T | 7.4% | D70E (GAT→GAA) | ahpC2 ← | possible peroxiredoxin |
RA | 1,862,048 | A→G | 5.3% | V709A (GTT→GCT) | sftA ← | DNA translocase |
RA | 1,868,200 | C→T | 5.1% | V132I (GTT→ATT) | ytnP ← | possible metal‑dependent hydrolase |
RA | 1,929,796 | T→C | 19.7% | intergenic (‑879/‑289) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,797 | G→A | 19.4% | intergenic (‑880/‑288) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,799 | C→A | 19.4% | intergenic (‑882/‑286) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,804 | A→G | 20.3% | intergenic (‑887/‑281) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,812 | G→A | 30.5% | intergenic (‑895/‑273) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,843 | Δ1 bp | 38.9% | intergenic (‑926/‑242) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,848 | C→A | 39.4% | intergenic (‑931/‑237) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,861 | T→C | 41.1% | intergenic (‑944/‑224) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,862:1 | +T | 33.7% | intergenic (‑945/‑223) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,864 | A→T | 6.6% | intergenic (‑947/‑221) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,865 | A→C | 33.4% | intergenic (‑948/‑220) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,866 | G→T | 39.1% | intergenic (‑949/‑219) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,867 | G→T | 40.2% | intergenic (‑950/‑218) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,870 | A→C | 40.0% | intergenic (‑953/‑215) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,872 | G→A | 39.6% | intergenic (‑955/‑213) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,873 | C→A | 40.0% | intergenic (‑956/‑212) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,875 | T→C | 40.2% | intergenic (‑958/‑210) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,917 | C→T | 35.9% | intergenic (‑1000/‑168) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,918 | A→G | 36.4% | intergenic (‑1001/‑167) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,925 | T→A | 31.5% | intergenic (‑1008/‑160) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,928 | T→A | 31.5% | intergenic (‑1011/‑157) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,930 | T→A | 31.6% | intergenic (‑1013/‑155) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,941 | A→T | 23.3% | intergenic (‑1024/‑144) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,929,946 | G→A | 17.9% | intergenic (‑1029/‑139) | USA300HOU_1794 ← / → USA300HOU_1796 | hypothetical protein/hypothetical protein |
RA | 1,935,301 | C→A | 5.5% | intergenic (‑54/+1092) | USA300HOU_1798 ← / ← hsdS2 | hypothetical protein/type I site‑specific deoxyribonuclease specificity subunit |
RA | 1,942,634 | T→C | 5.1% | K58K (AAA→AAG) | splC ← | S1B family serine protease SplC |
RA | 1,963,502 | C→T | 7.6% | T453T (ACG→ACA) | hemG ← | protoporphyrinogen oxidase |
RA | 1,967,670 | T→C | 5.5% | intergenic (+2/+122) | traP → / ← ecsB | RNAIII‑activating protein TRAP/ABC superfamily ATP binding cassette transporter, membrane protein |
RA | 1,970,814 | G→C | 5.1% | intergenic (+3/‑730) | USA300HOU_1831 → / → USA300HOU_1832 | hypothetical protein/hypothetical membrane protein |
RA | 1,970,932 | A→T | 5.2% | intergenic (+121/‑612) | USA300HOU_1831 → / → USA300HOU_1832 | hypothetical protein/hypothetical membrane protein |
RA | 1,997,013 | C→G | 5.5% | noncoding (61/93 nt) | USA300HOU_t0037 ← | tRNA‑Ser |
RA | 1,997,022 | G→C | 8.2% | noncoding (52/93 nt) | USA300HOU_t0037 ← | tRNA‑Ser |
RA | 2,005,544 | G→A | 5.7% | S37S (AGC→AGT) | pdxB ← | D‑3‑phosphoglycerate dehydrogenase |
RA | 2,010,363 | C→T | 100% | C146Y (TGT→TAT) | ygaD ← | ABC superfamily ATP binding cassette transporter, membrane protein |
RA | 2,012,683 | G→A | 5.5% | H97Y (CAT→TAT) | mutY ← | A/G‑specific DNA glycosylase |
RA | 2,016,103 | G→A | 6.2% | Y207Y (TAC→TAT) | rgpD ← | teichoic acid ABC superfamily ATP binding cassette transporter, ABC protein |
RA | 2,027,805 | C→A | 5.2% | V48F (GTT→TTT) | vraS ← | sensor histidine kinase VraS |
RA | 2,070,643 | T→C | 6.7% | A64A (GCA→GCG) | ykgB ← | hypothetical protein |
RA | 2,079,751 | C→T | 5.0% | Q139Q (CAG→CAA) | bcrA ← | GntR family transcriptional regulator |
RA | 2,086,482 | G→T | 7.1% | intergenic (‑372/+17) | USA300HOU_1945 ← / ← USA300HOU_1946 | hypothetical protein/hypothetical protein |
RA | 2,086,484 | A→T | 7.1% | intergenic (‑374/+15) | USA300HOU_1945 ← / ← USA300HOU_1946 | hypothetical protein/hypothetical protein |
RA | 2,086,485 | A→T | 8.1% | intergenic (‑375/+14) | USA300HOU_1945 ← / ← USA300HOU_1946 | hypothetical protein/hypothetical protein |
RA | 2,086,487 | A→C | 7.3% | intergenic (‑377/+12) | USA300HOU_1945 ← / ← USA300HOU_1946 | hypothetical protein/hypothetical protein |
RA | 2,091,346 | T→C | 5.8% | G85G (GGA→GGG) | USA300HOU_1954 ← | hypothetical bacteriophage protein |
RA | 2,091,517 | A→G | 5.9% | N28N (AAT→AAC) | USA300HOU_1954 ← | hypothetical bacteriophage protein |
RA | 2,110,877 | G→A | 7.3% | intergenic (‑123/+109) | USA300HOU_1973 ← / ← USA300HOU_1974 | hypothetical protein/hypothetical bacteriophage protein |
RA | 2,110,918 | T→C | 7.7% | intergenic (‑164/+68) | USA300HOU_1973 ← / ← USA300HOU_1974 | hypothetical protein/hypothetical bacteriophage protein |
RA | 2,119,129 | T→C | 6.4% | M373V (ATG→GTG) | USA300HOU_1992 ← | hypothetical protein |
RA | 2,119,277 | C→T | 8.0% | T323T (ACG→ACA) | USA300HOU_1992 ← | hypothetical protein |
RA | 2,119,307 | C→T | 5.6% | T313T (ACG→ACA) | USA300HOU_1992 ← | hypothetical protein |
RA | 2,119,319 | T→C | 5.6% | A309A (GCA→GCG) | USA300HOU_1992 ← | hypothetical protein |
RA | 2,119,322 | T→A | 5.3% | V308V (GTA→GTT) | USA300HOU_1992 ← | hypothetical protein |
RA | 2,119,345 | A→G | 6.0% | L301L (TTA→CTA) | USA300HOU_1992 ← | hypothetical protein |
RA | 2,119,346 | T→C | 6.2% | E300E (GAA→GAG) | USA300HOU_1992 ← | hypothetical protein |
RA | 2,119,364 | G→T | 5.7% | I294I (ATC→ATA) | USA300HOU_1992 ← | hypothetical protein |
RA | 2,119,733 | A→G | 5.9% | I171I (ATT→ATC) | USA300HOU_1992 ← | hypothetical protein |
RA | 2,119,757 | C→T | 5.7% | K163K (AAG→AAA) | USA300HOU_1992 ← | hypothetical protein |
RA | 2,120,542 | T→C | 5.1% | K78R (AAA→AGA) | USA300HOU_1994 ← | hypothetical bacteriophage protein |
RA | 2,120,582 | C→T | 8.9% | V65I (GTT→ATT) | USA300HOU_1994 ← | hypothetical bacteriophage protein |
RA | 2,120,625 | A→G | 8.5% | D50D (GAT→GAC) | USA300HOU_1994 ← | hypothetical bacteriophage protein |
RA | 2,120,639 | A→G | 9.0% | L46L (TTA→CTA) | USA300HOU_1994 ← | hypothetical bacteriophage protein |
RA | 2,120,664 | G→A | 9.8% | D37D (GAC→GAT) | USA300HOU_1994 ← | hypothetical bacteriophage protein |
RA | 2,120,669 | G→A | 8.4% | L36L (CTA→TTA) | USA300HOU_1994 ← | hypothetical bacteriophage protein |
RA | 2,120,673 | A→G | 7.9% | V34V (GTT→GTC) | USA300HOU_1994 ← | hypothetical bacteriophage protein |
RA | 2,120,676 | C→T | 7.7% | M33I (ATG→ATA) | USA300HOU_1994 ← | hypothetical bacteriophage protein |
RA | 2,120,685 | G→A | 8.1% | S30S (AGC→AGT) | USA300HOU_1994 ← | hypothetical bacteriophage protein |
RA | 2,120,691 | C→T | 6.3% | A28A (GCG→GCA) | USA300HOU_1994 ← | hypothetical bacteriophage protein |
RA | 2,120,697 | T→C | 6.1% | K26K (AAA→AAG) | USA300HOU_1994 ← | hypothetical bacteriophage protein |
RA | 2,140,625 | T→G | 5.4% | E488A (GAA→GCA) | groEL ← | chaperone GroEL |
RA | 2,145,638 | A→G | 5.1% | intergenic (+172/‑189) | USA300HOU_2028 → / → orf5 | possible nitroreductase/amidohydrolase |
RA | 2,160,679 | A→T | 5.4% | intergenic (‑3432/‑49) | USA300HOU_2042 ← / → mutS2 | hypothetical membrane protein/possible DNA mismatch repair protein MutS |
RA | 2,189,877 | G→T | 7.2% | R100R (CGA→AGA) | alr2 ← | alanine racemase |
RA | 2,250,701 | G→A | 5.4% | G361G (GGC→GGT) | hmrA ← | M20D subfamily peptidase |
RA | 2,257,029 | C→A | 5.4% | intergenic (‑118/+82) | dps ← / ← yuxK | Dps family stress protein/hypothetical protein |
RA | 2,257,030 | C→T | 5.1% | intergenic (‑119/+81) | dps ← / ← yuxK | Dps family stress protein/hypothetical protein |
RA | 2,257,055 | C→T | 7.0% | intergenic (‑144/+56) | dps ← / ← yuxK | Dps family stress protein/hypothetical protein |
RA | 2,257,078 | A→G | 6.3% | intergenic (‑167/+33) | dps ← / ← yuxK | Dps family stress protein/hypothetical protein |
RA | 2,279,705 | G→A | 100% | intergenic (+1373/+6659) | mtlD → / ← glmM | mannitol‑1‑phosphate 5‑dehydrogenase/phosphoglucosamine mutase |
RA | 2,280,118 | A→T | 6.2% | intergenic (+1786/+6246) | mtlD → / ← glmM | mannitol‑1‑phosphate 5‑dehydrogenase/phosphoglucosamine mutase |
RA | 2,282,111 | G→T | 7.4% | intergenic (+3779/+4253) | mtlD → / ← glmM | mannitol‑1‑phosphate 5‑dehydrogenase/phosphoglucosamine mutase |
RA | 2,283,526 | A→C | 5.1% | intergenic (+5194/+2838) | mtlD → / ← glmM | mannitol‑1‑phosphate 5‑dehydrogenase/phosphoglucosamine mutase |
RA | 2,284,721 | T→G | 5.3% | intergenic (+6389/+1643) | mtlD → / ← glmM | mannitol‑1‑phosphate 5‑dehydrogenase/phosphoglucosamine mutase |
RA | 2,284,800 | T→C | 6.8% | intergenic (+6468/+1564) | mtlD → / ← glmM | mannitol‑1‑phosphate 5‑dehydrogenase/phosphoglucosamine mutase |
RA | 2,291,888 | G→A | 8.7% | K359K (AAG→AAA) | USA300HOU_2155 → | transposase |
RA | 2,292,012 | T→C | 7.5% | *401R (TGA→CGA) | USA300HOU_2155 → | transposase |
RA | 2,292,077 | G→A | 12.4% | intergenic (+63/‑73) | USA300HOU_2155 → / → USA300HOU_2156 | transposase/hypothetical protein |
RA | 2,292,140 | G→A | 5.8% | intergenic (+126/‑10) | USA300HOU_2155 → / → USA300HOU_2156 | transposase/hypothetical protein |
RA | 2,313,472 | G→A | 6.6% | D206D (GAC→GAT) | rhbC ← | possible Iuc family aerobactin synthesis protein |
RA | 2,330,500 | A→G | 5.4% | F161F (TTT→TTC) | lacD ← | tagatose‑bisphosphate aldolase |
RA | 2,330,506 | T→A | 5.2% | P159P (CCA→CCT) | lacD ← | tagatose‑bisphosphate aldolase |
RA | 2,330,512 | A→G | 5.5% | D157D (GAT→GAC) | lacD ← | tagatose‑bisphosphate aldolase |
RA | 2,330,698 | T→A | 5.2% | G95G (GGA→GGT) | lacD ← | tagatose‑bisphosphate aldolase |
RA | 2,337,959 | C→T | 5.8% | intergenic (‑125/‑119) | adhR ← / → USA300HOU_2196 | possible MerR family transcriptional regulator/hypothetical protein |
RA | 2,338,218 | G→A | 5.2% | A47A (GCG→GCA) | USA300HOU_2196 → | hypothetical protein |
RA | 2,338,816 | A→G | 5.2% | K194R (AAA→AGA) | hysA → | hyaluronate lyase |
RA | 2,338,908 | G→A | 6.4% | D225N (GAT→AAT) ‡ | hysA → | hyaluronate lyase |
RA | 2,338,910 | T→A | 6.4% | D225E (GAT→GAA) ‡ | hysA → | hyaluronate lyase |
RA | 2,343,438 | C→T | 7.6% | intergenic (+114/+250) | USA300HOU_2200 → / ← alsD | hypothetical protein/acetolactate decarboxylase |
RA | 2,346,247 | G→T | 5.0% | intergenic (‑154/‑94) | alsS ← / → USA300HOU_2203 | acetolactate synthase/hypothetical protein |
RA | 2,372,413 | C→G | 7.0% | intergenic (‑5530/+28) | rpmC ← / ← pbuG | ribosomal protein L29/NCS2 family nucleobase:cation symporter‑2 |
RA | 2,372,419 | C→T | 8.4% | intergenic (‑5536/+22) | rpmC ← / ← pbuG | ribosomal protein L29/NCS2 family nucleobase:cation symporter‑2 |
RA | 2,378,942 | C→T | 5.7% | S182N (AGT→AAT) | USA300HOU_2240 ← | AEC family malonate efflux carrier |
RA | 2,379,107 | A→C | 5.2% | V127G (GTT→GGT) | USA300HOU_2240 ← | AEC family malonate efflux carrier |
RA | 2,379,121 | T→C | 8.6% | G122G (GGA→GGG) | USA300HOU_2240 ← | AEC family malonate efflux carrier |
RA | 2,379,394 | T→C | 7.9% | K31K (AAA→AAG) | USA300HOU_2240 ← | AEC family malonate efflux carrier |
RA | 2,379,661 | A→T | 5.2% | I21L (ATA→TTA) | USA300HOU_2241 → | hypothetical protein |
RA | 2,394,482 | T→A | 7.6% | D27V (GAT→GTT) | moaB ← | molybdopterin cofactor biosynthesis protein MoaB |
RA | 2,398,692 | T→C | 5.3% | I188I (ATT→ATC) | fdhD → | formate dehydrogenase accessory protein FdhD |
RA | 2,403,072 | A→T | 5.1% | intergenic (‑209/+5) | fhuD ← / ← USA300HOU_2267 | iron (Fe+3) ABC superfamily ATP binding cassette transporter, binding protein/acyl‑CoA dehydrogenase |
RA | 2,413,174 | T→C | 6.3% | L522L (TTA→TTG) | USA300HOU_2279 ← | transcriptional regulator |
RA | 2,413,192 | C→A | 6.7% | S516S (TCG→TCT) ‡ | USA300HOU_2279 ← | transcriptional regulator |
RA | 2,413,194 | A→C | 6.9% | S516A (TCG→GCG) ‡ | USA300HOU_2279 ← | transcriptional regulator |
RA | 2,413,260 | A→T | 6.4% | S494T (TCT→ACT) | USA300HOU_2279 ← | transcriptional regulator |
RA | 2,413,272 | T→A | 6.5% | I490F (ATT→TTT) | USA300HOU_2279 ← | transcriptional regulator |
RA | 2,421,323 | T→C | 5.5% | D131D (GAT→GAC) | gyaR → | (R)‑2‑hydroxyacid dehydrogenase |
RA | 2,426,760 | A→T | 5.7% | G446G (GGT→GGA) | USA300HOU_2291 ← | formate dehydrogenase alpha subunit |
RA | 2,428,236 | A→G | 6.2% | intergenic (‑139/+463) | USA300HOU_2291 ← / ← lytR | formate dehydrogenase alpha subunit/transcriptional regulator |
RA | 2,444,143 | G→A | 5.2% | I257I (ATC→ATT) | USA300HOU_2306 ← | NhaC family sodium:proton (Na+:H) antiporter |
RA | 2,475,761 | T→C | 6.0% | T165T (ACA→ACG) | tcaA ← | teicoplanin resistance protein TcaA |
RA | 2,479,526 | A→G | 6.6% | G108G (GGT→GGC) | htrB ← | hemin ABC superfamily ATP binding cassette transporter, ABC protein |
RA | 2,524,206 | A→C | 7.3% | A142A (GCT→GCG) | nirB ← | nitrite reductase (NAD(P)H) large subunit |
RA | 2,524,238 | G→T | 6.9% | L132I (CTT→ATT) | nirB ← | nitrite reductase (NAD(P)H) large subunit |
RA | 2,528,070 | G→T | 6.8% | intergenic (‑936/+317) | USA300HOU_2385 ← / ← adcA | FNT family formate‑nitrite transporter/ABC superfamily ATP binding cassette transporter, binding protein |
RA | 2,528,079 | G→C | 7.2% | intergenic (‑945/+308) | USA300HOU_2385 ← / ← adcA | FNT family formate‑nitrite transporter/ABC superfamily ATP binding cassette transporter, binding protein |
RA | 2,528,110 | G→T | 8.3% | intergenic (‑976/+277) | USA300HOU_2385 ← / ← adcA | FNT family formate‑nitrite transporter/ABC superfamily ATP binding cassette transporter, binding protein |
RA | 2,532,298 | A→T | 100% | T15T (ACA→ACT) | murN → | FemAB family peptidoglycan biosynthesis protein |
RA | 2,542,070 | G→A | 5.3% | intergenic (+329/‑171) | USA300HOU_2401 → / → hlgA | immunoglobulin G‑binding protein SBI/gamma‑hemolysin component A |
RA | 2,559,032 | T→A | 6.2% | V146V (GTT→GTA) | bcr → | MFS family major facilitator transporter, bicyclomycin:cation symporter |
RA | 2,559,830 | A→G | 7.4% | intergenic (+24/+99) | bcr → / ← USA300HOU_2421 | MFS family major facilitator transporter, bicyclomycin:cation symporter/hypothetical protein |
RA | 2,559,831 | G→A | 7.3% | intergenic (+25/+98) | bcr → / ← USA300HOU_2421 | MFS family major facilitator transporter, bicyclomycin:cation symporter/hypothetical protein |
RA | 2,559,840 | T→G | 9.1% | intergenic (+34/+89) | bcr → / ← USA300HOU_2421 | MFS family major facilitator transporter, bicyclomycin:cation symporter/hypothetical protein |
RA | 2,559,841 | C→A | 8.9% | intergenic (+35/+88) | bcr → / ← USA300HOU_2421 | MFS family major facilitator transporter, bicyclomycin:cation symporter/hypothetical protein |
RA | 2,559,850 | T→C | 9.0% | intergenic (+44/+79) | bcr → / ← USA300HOU_2421 | MFS family major facilitator transporter, bicyclomycin:cation symporter/hypothetical protein |
RA | 2,559,851 | C→T | 8.7% | intergenic (+45/+78) | bcr → / ← USA300HOU_2421 | MFS family major facilitator transporter, bicyclomycin:cation symporter/hypothetical protein |
RA | 2,565,219 | C→A | 5.3% | I449I (ATC→ATA) | nhaK → | CPA1 family monovalent cation:proton (H+) antiporter‑1 |
RA | 2,590,449 | C→T | 5.5% | Y31Y (TAC→TAT) | USA300HOU_2452 → | hypothetical protein |
RA | 2,590,473 | G→A | 5.6% | P39P (CCG→CCA) | USA300HOU_2452 → | hypothetical protein |
RA | 2,596,746 | T→C | 5.8% | T252T (ACA→ACG) | nikA ← | oligopeptide ABC superfamily ATP binding cassette transporter, binding protein |
RA | 2,614,089 | A→G | 5.2% | N194N (AAT→AAC) | USA300HOU_2478 ← | lipoprotein |
RA | 2,614,095 | T→C | 5.2% | L192L (TTA→TTG) | USA300HOU_2478 ← | lipoprotein |
RA | 2,614,104 | C→T | 5.2% | K189K (AAG→AAA) | USA300HOU_2478 ← | lipoprotein |
RA | 2,614,110 | T→G | 5.3% | S187S (TCA→TCC) | USA300HOU_2478 ← | lipoprotein |
RA | 2,620,750 | A→T | 5.7% | intergenic (+47/‑97) | USA300HOU_2483 → / → USA300HOU_2484 | hypothetical protein/hypothetical membrane protein |
RA | 2,622,662 | A→G | 5.9% | Y3Y (TAT→TAC) | USA300HOU_2485 ← | MFS family major facilitator transporter, cation symporter |
RA | 2,622,711:1 | +C | 5.4% | intergenic (‑41/+3995) | USA300HOU_2485 ← / ← sarT | MFS family major facilitator transporter, cation symporter/staphylococcal accessory regulator T |
RA | 2,627,279 | A→T | 6.1% | intergenic (‑214/‑108) | sarT ← / → sarU | staphylococcal accessory regulator T/staphylococcal accessory regulator U |
RA | 2,653,179 | C→T | 5.8% | L584L (CTA→TTA) ‡ | fbp → | fructose‑bisphosphatase |
RA | 2,653,181 | A→G | 5.5% | L584L (CTA→CTG) ‡ | fbp → | fructose‑bisphosphatase |
RA | 2,653,199 | T→A | 5.4% | G590G (GGT→GGA) | fbp → | fructose‑bisphosphatase |
RA | 2,654,169 | C→T | 5.8% | G144G (GGC→GGT) | USA300HOU_2507 → | hypothetical membrane protein |
RA | 2,654,172 | T→A | 5.9% | G145G (GGT→GGA) | USA300HOU_2507 → | hypothetical membrane protein |
RA | 2,654,178 | C→T | 6.4% | T147T (ACC→ACT) | USA300HOU_2507 → | hypothetical membrane protein |
RA | 2,654,193 | G→A | 5.5% | A152A (GCG→GCA) | USA300HOU_2507 → | hypothetical membrane protein |
RA | 2,668,042 | A→G | 6.3% | Y50Y (TAT→TAC) | USA300HOU_2523 ← | transcriptional regulator |
RA | 2,668,363 | G→A | 5.0% | intergenic (‑172/‑738) | USA300HOU_2523 ← / → yicL | transcriptional regulator/DMT superfamily drug/metabolite transporter |
RA | 2,690,959 | A→G | 5.9% | L560L (TTA→CTA) | USA300HOU_2546 ← | RND superfamily resistance‑nodulation‑cell division:proton (H+) antiporter |
RA | 2,690,960 | T→C | 5.8% | T559T (ACA→ACG) | USA300HOU_2546 ← | RND superfamily resistance‑nodulation‑cell division:proton (H+) antiporter |
RA | 2,696,558 | T→C | 7.5% | intergenic (+110/‑130) | USA300HOU_2551 → / → copA | hypothetical protein/P‑ATPase superfamily P‑type ATPase copper (Cu2+) transporter |
RA | 2,696,559 | T→C | 7.6% | intergenic (+111/‑129) | USA300HOU_2551 → / → copA | hypothetical protein/P‑ATPase superfamily P‑type ATPase copper (Cu2+) transporter |
RA | 2,696,979 | G→A | 6.7% | D98N (GAC→AAC) | copA → | P‑ATPase superfamily P‑type ATPase copper (Cu2+) transporter |
RA | 2,701,484 | A→G | 5.1% | D125D (GAT→GAC) | mtnE ← | aminotransferase |
RA | 2,721,481 | T→C | 10.9% | L198S (TTA→TCA) | USA300HOU_2575 → | hydrolase |
RA | 2,721,513 | A→G | 9.2% | N209D (AAT→GAT) | USA300HOU_2575 → | hydrolase |
RA | 2,725,352 | A→T | 5.9% | intergenic (‑58/+276) | ynzC ← / ← ynzC | hypothetical protein/hypothetical protein |
RA | 2,726,571 | C→T | 5.4% | M1M (ATG→ATA) † | USA300HOU_2581 ← | hypothetical protein |
RA | 2,726,585 | T→C | 5.3% | intergenic (‑12/+330) | USA300HOU_2581 ← / ← USA300HOU_2582 | hypothetical protein/hypothetical protein |
RA | 2,752,055 | G→A | 5.2% | F283F (TTC→TTT) | betB ← | betaine‑aldehyde dehydrogenase |
RA | 2,772,254 | T→G | 5.8% | S351S (TCT→TCG) | phoB → | alkaline phosphatase |
RA | 2,775,041 | A→G | 6.6% | D715D (GAT→GAC) | clfB ← | clumping factor B |
RA | 2,797,717 | Δ1 bp | 5.2% | intergenic (+5/+262) | acmB → / ← USA300HOU_2645 | possible N‑acetylmuramoyl‑L‑alanine amidase/possible isochorismatase hydrolase |
RA | 2,797,718 | Δ1 bp | 5.2% | intergenic (+6/+261) | acmB → / ← USA300HOU_2645 | possible N‑acetylmuramoyl‑L‑alanine amidase/possible isochorismatase hydrolase |
RA | 2,797,730 | T→C | 5.5% | intergenic (+18/+249) | acmB → / ← USA300HOU_2645 | possible N‑acetylmuramoyl‑L‑alanine amidase/possible isochorismatase hydrolase |
RA | 2,797,788 | T→C | 5.6% | intergenic (+76/+191) | acmB → / ← USA300HOU_2645 | possible N‑acetylmuramoyl‑L‑alanine amidase/possible isochorismatase hydrolase |
RA | 2,803,218 | A→G | 5.6% | F166F (TTT→TTC) | gtf1 ← | possible glycosyltransferase |
RA | 2,831,977 | G→T | 11.4% | Q230K (CAA→AAA) | lip ← | triacylglycerol lipase |
RA | 2,867,125 | A→G | 6.8% | L257L (TTA→CTA) | noc ← | possible transcriptional regulator |
RA | 2,870,578 | G→A | 5.2% | intergenic (‑46/+21) | gidA ← / ← mnmE | glucose inhibited division protein A/GTP‑binding protein |
Unassigned new junction evidence | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
* | ? | CP000730 | 62771 = | 24 (0.270) | 7 (0.080) | 3/240 | NT | 34.7% | intergenic (+36/+275) | USA300HOU_0056/speG | hypothetical protein/diamine N‑acetyltransferase |
? | CP000730 | 62827 = | 4 (0.050) | intergenic (+92/+219) | USA300HOU_0056/speG | hypothetical protein/diamine N‑acetyltransferase | |||||
* | ? | CP000730 | = 399701 | 72 (0.810) | 5 (0.060) | 4/236 | NT | 7.0% | intergenic (+9/+83) | USA300HOU_0366/tatC | OFeT family oxidase‑dependent iron (Fe2+) transporter/Tat family twin arginine targeting transporter TatC |
? | CP000730 | = 399706 | 68 (0.840) | intergenic (+14/+78) | USA300HOU_0366/tatC | OFeT family oxidase‑dependent iron (Fe2+) transporter/Tat family twin arginine targeting transporter TatC | |||||
* | ? | CP000730 | 512620 = | 112 (1.260) | 69 (1.130) +40 bp |
50/178 | NT | 47.2% | intergenic (+688/‑173) | recR/rrs1 | recombination protein RecR/16S ribosomal RNA |
? | CP000730 | 1998278 = | NA (NA) | intergenic (‑6/+5) | USA300HOU_t0050/rrf4 | tRNA‑Val/5S ribosomal RNA | |||||
* | ? | CP000730 | 514644 = | NA (NA) | 11 (0.130) +TGG |
3/252 | NT | 84.9% | intergenic (+312/‑62) | rrs1/rrl1 | 16S ribosomal RNA/23S ribosomal RNA |
? | CP000730 | 558945 = | 2 (0.020) | intergenic (+158/‑12) | USA300HOU_t0012/rrl2 | tRNA‑Ile/23S ribosomal RNA | |||||
* | ? | CP000730 | = 515946 | NA (NA) | 4 (0.050) | 3/244 | NT | NA | noncoding (1241/2921 nt) | rrl1 | 23S ribosomal RNA |
? | CP000730 | = 515981 | NA (NA) | noncoding (1276/2921 nt) | rrl1 | 23S ribosomal RNA | |||||
* | ? | CP000730 | 613921 = | 116 (1.310) | 6 (0.070) | 4/252 | NT | 5.3% | coding (2233/2844 nt) | sdrC | Ser‑Asp rich fibrinogen/bone sialoprotein‑binding protein SdrC |
? | CP000730 | = 618408 | 103 (1.190) | coding (3510/4146 nt) | sdrD | Ser‑Asp rich fibrinogen/bone sialoprotein‑binding protein SdrD | |||||
* | ? | CP000730 | = 760039 | 79 (0.890) | 10 (0.130) | 8/230 | NT | 12.2% | intergenic (+13/+114) | cydC/USA300HOU_0709 | ABC superfamily ATP binding cassette transporter, ABC protein/possible MarR family transcriptional regulator |
? | CP000730 | = 760055 | 74 (0.940) | intergenic (+29/+98) | cydC/USA300HOU_0709 | ABC superfamily ATP binding cassette transporter, ABC protein/possible MarR family transcriptional regulator | |||||
* | ? | CP000730 | = 801934 | 87 (0.980) | 5 (0.060) +C |
3/256 | NT | 5.5% | intergenic (+175/+449) | USA300HOU_0748/dgkA1 | hypothetical protein/possible diacylglycerol kinase |
? | CP000730 | = 2145702 | 86 (0.970) | intergenic (+236/‑125) | USA300HOU_2028/orf5 | possible nitroreductase/amidohydrolase | |||||
* | ? | CP000730 | 830841 = | 91 (1.030) | 4 (0.050) | 4/234 | NT | 5.0% | intergenic (+10/‑404) | raiA/secA1 | possible ribosome‑associated inhibitor protein Y/Sec family Type I general secretory pathway preprotein translocase subunit SecA |
? | CP000730 | 830871 = | 68 (0.850) | intergenic (+40/‑374) | raiA/secA1 | possible ribosome‑associated inhibitor protein Y/Sec family Type I general secretory pathway preprotein translocase subunit SecA | |||||
* | ? | CP000730 | = 885389 | 50 (0.560) | 5 (0.060) | 4/232 | NT | 9.3% | intergenic (+18/+55) | gpmA1/yisU | phosphoglycerate mutase/LysE family L‑lysine exporter |
? | CP000730 | = 885408 | 52 (0.650) | intergenic (+37/+36) | gpmA1/yisU | phosphoglycerate mutase/LysE family L‑lysine exporter | |||||
* | ? | CP000730 | 893176 = | 88 (0.990) | 7 (0.090) | 6/234 | NT | 8.6% | intergenic (+177/‑73) | USA300HOU_0846/metN | possible thioredoxin/ABC superfamily ATP binding cassette transporter, ABC protein |
? | CP000730 | 893212 = | 69 (0.860) | intergenic (+213/‑37) | USA300HOU_0846/metN | possible thioredoxin/ABC superfamily ATP binding cassette transporter, ABC protein | |||||
* | ? | CP000730 | = 920390 | 76 (0.860) | 4 (0.050) | 4/230 | NT | 5.9% | coding (39/135 nt) | USA300HOU_0880 | hypothetical protein |
? | CP000730 | = 920428 | 60 (0.760) | coding (1/135 nt) | USA300HOU_0880 | hypothetical protein | |||||
* | ? | CP000730 | = 932471 | 86 (0.970) | 7 (0.090) | 7/234 | NT | 8.0% | intergenic (+17/+246) | dltD/nifU | D‑alanine transfer protein DltD/possible NifU family protein |
? | CP000730 | = 932493 | 84 (1.050) | intergenic (+39/+224) | dltD/nifU | D‑alanine transfer protein DltD/possible NifU family protein | |||||
* | ? | CP000730 | 940816 = | 83 (0.940) | 5 (0.060) | 4/246 | NT | 5.6% | coding (372/375 nt) | comA | hypothetical protein |
? | CP000730 | 940879 = | 90 (1.070) | coding (1151/1155 nt) | USA300HOU_0905 | hypothetical protein | |||||
* | ? | CP000730 | 1072168 = | 94 (1.060) | 5 (0.060) | 3/256 | NT | 5.5% | intergenic (‑640/+165) | iraE/folD | possible chitinase/bifunctional methylenetetrahydrofolate dehydrogenase (NADP(+))/methenyltetrahydrofolate cyclohydrolase |
? | CP000730 | 2716787 = | 79 (0.900) | intergenic (+95/+55) | ynzC/USA300HOU_2569 | hypothetical protein/possible lactoylglutatione lyase | |||||
* | ? | CP000730 | 1129293 = | 77 (0.870) | 6 (0.070) | 5/242 | NT | 7.8% | intergenic (+71/‑256) | USA300HOU_1055/USA300HOU_1056 | hypothetical membrane protein/hypothetical protein |
? | CP000730 | 1129331 = | 69 (0.830) | intergenic (+109/‑218) | USA300HOU_1055/USA300HOU_1056 | hypothetical membrane protein/hypothetical protein | |||||
* | ? | CP000730 | = 1205323 | 76 (0.860) | 35 (0.560) +38 bp |
7/182 | NT | 38.0% | intergenic (+459/‑365) | yfiE/lspA | possible lactoylglutathione lyase/A8 family signal peptidase II |
? | CP000730 | 2478252 = | 86 (0.970) | intergenic (+139/+932) | USA300HOU_2340/htrB | hypothetical membrane protein/hemin ABC superfamily ATP binding cassette transporter, ABC protein | |||||
* | ? | CP000730 | 1380211 = | 58 (0.650) | 4 (0.050) | 3/234 | NT | 7.4% | intergenic (+2308/‑867) | sbcC/acnA | exodeoxyribonuclease SbcC/aconitate hydratase |
? | CP000730 | 1380259 = | 48 (0.600) | intergenic (+2356/‑819) | sbcC/acnA | exodeoxyribonuclease SbcC/aconitate hydratase | |||||
* | ? | CP000730 | = 1380222 | 55 (0.620) | 4 (0.050) | 4/234 | NT | 7.6% | intergenic (+2319/‑856) | sbcC/acnA | exodeoxyribonuclease SbcC/aconitate hydratase |
? | CP000730 | = 1380246 | 48 (0.600) | intergenic (+2343/‑832) | sbcC/acnA | exodeoxyribonuclease SbcC/aconitate hydratase | |||||
* | ? | CP000730 | 1575673 = | 81 (0.910) | 7 (0.080) | 5/248 | NT | 8.2% | coding (1844/6201 nt) | hlgB | possible bacteriophage tail protein |
? | CP000730 | 1575710 = | 78 (0.920) | coding (1807/6201 nt) | hlgB | possible bacteriophage tail protein | |||||
* | ? | CP000730 | = 1676788 | 77 (0.870) | 5 (0.060) | 5/254 | NT | 6.2% | intergenic (‑894/‑75) | USA300HOU_1565/glyS | hypothetical protein/glycine‑‑tRNA ligase |
? | CP000730 | = 1676835 | 75 (0.860) | intergenic (‑941/‑28) | USA300HOU_1565/glyS | hypothetical protein/glycine‑‑tRNA ligase | |||||
* | ? | CP000730 | = 1709558 | 55 (0.620) | 6 (0.070) | 4/244 | NT | 10.2% | intergenic (‑97/+365) | sem/USA300HOU_1604 | enterotoxin/hypothetical protein |
? | CP000730 | = 1709579 | 54 (0.640) | intergenic (‑118/+344) | sem/USA300HOU_1604 | enterotoxin/hypothetical protein | |||||
* | ? | CP000730 | 1822865 = | 93 (1.050) | 5 (0.060) | 5/240 | NT | 5.6% | intergenic (+186/+60) | USA300HOU_1697/ackA | possible universal stress protein/acetate kinase |
? | CP000730 | 1822909 = | 83 (1.010) | intergenic (+230/+16) | USA300HOU_1697/ackA | possible universal stress protein/acetate kinase | |||||
* | ? | CP000730 | = 1843478 | 53 (0.600) | 3 (0.040) | 3/240 | NT | 5.4% | intergenic (‑162/‑220) | tyrS/sgtA | tyrosine‑‑tRNA ligase/possible transglycosylase |
? | CP000730 | = 1843483 | 55 (0.670) | intergenic (‑167/‑215) | tyrS/sgtA | tyrosine‑‑tRNA ligase/possible transglycosylase | |||||
* | ? | CP000730 | = 1878614 | 74 (0.840) | 4 (0.050) | 4/222 | NT | 5.4% | intergenic (+73/+44) | ytfP/fmtB1 | possible flavoprotein/cell surface anchored protein |
? | CP000730 | = 1878633 | 77 (1.010) | intergenic (+92/+25) | ytfP/fmtB1 | possible flavoprotein/cell surface anchored protein | |||||
* | ? | CP000730 | = 1920358 | 81 (0.910) | 5 (0.060) | 4/250 | NT | 6.2% | coding (968/1002 nt) | menC | possible o‑succinylbenzoic acid (OSB) synthetase |
? | CP000730 | = 1920382 | 73 (0.850) | coding (944/1002 nt) | menC | possible o‑succinylbenzoic acid (OSB) synthetase | |||||
* | ? | CP000730 | 1994322 = | NA (NA) | 3 (0.040) | 3/246 | NT | 25.9% | intergenic (‑429/‑64) | USA300HOU_1854/USA300HOU_1855 | hypothetical protein/IS1181 transposase |
? | CP000730 | 1994387 = | 9 (0.100) | coding (2/1362 nt) | USA300HOU_1855 | IS1181 transposase | |||||
* | ? | CP000730 | 1998448 = | NA (NA) | 5 (0.060) | 5/246 | NT | NA | intergenic (‑52/+23) | rrf4/rrl3 | 5S ribosomal RNA/23S ribosomal RNA |
? | CP000730 | 1998463 = | NA (NA) | intergenic (‑67/+8) | rrf4/rrl3 | 5S ribosomal RNA/23S ribosomal RNA | |||||
* | ? | CP000730 | 2008942 = | 88 (0.990) | 4 (0.050) | 4/230 | NT | 5.4% | intergenic (+70/+121) | ygaE/ygaD | hypothetical membrane protein/ABC superfamily ATP binding cassette transporter, membrane protein |
? | CP000730 | 2008991 = | 63 (0.800) | intergenic (+119/+72) | ygaE/ygaD | hypothetical membrane protein/ABC superfamily ATP binding cassette transporter, membrane protein | |||||
* | ? | CP000730 | 2053094 = | 80 (0.900) | 6 (0.070) | 5/242 | NT | 7.9% | intergenic (‑113/+59) | pcrB/yerC | PcrB family protein/possible Trp repressor |
? | CP000730 | 2053141 = | 64 (0.770) | intergenic (‑160/+12) | pcrB/yerC | PcrB family protein/possible Trp repressor | |||||
* | ? | CP000730 | = 2121978 | 0 (0.000) | 3 (0.040) | 3/244 | NT | 100% | coding (132/177 nt) | USA300HOU_1999 | hypothetical bacteriophage protein |
? | CP000730 | = 2122008 | NA (NA) | coding (102/177 nt) | USA300HOU_1999 | hypothetical bacteriophage protein | |||||
* | ? | CP000730 | 2248208 = | 83 (0.940) | 6 (0.070) | 6/248 | NT | 7.2% | intergenic (+2/+128) | coaA/USA300HOU_2120 | possible pantothenate kinase/hypothetical protein |
? | CP000730 | 2248263 = | 74 (0.870) | intergenic (+57/+73) | coaA/USA300HOU_2120 | possible pantothenate kinase/hypothetical protein | |||||
* | ? | CP000730 | 2252658 = | 94 (1.060) | 5 (0.060) | 4/246 | NT | 5.5% | intergenic (+94/+58) | luxS/USA300HOU_2124 | S‑ribosylhomocysteine lyase/hypothetical membrane protein |
? | CP000730 | 2252704 = | 82 (0.970) | intergenic (+140/+12) | luxS/USA300HOU_2124 | S‑ribosylhomocysteine lyase/hypothetical membrane protein | |||||
* | ? | CP000730 | 2336425 = | 69 (0.780) | 8 (0.100) | 8/236 | NT | 12.0% | intergenic (‑145/+75) | USA300HOU_2192/npdA | hypothetical protein/possible aldo/keto reductase |
? | CP000730 | 2336465 = | 54 (0.670) | intergenic (‑185/+35) | USA300HOU_2192/npdA | hypothetical protein/possible aldo/keto reductase | |||||
* | ? | CP000730 | 2361955 = | 103 (1.160) | 6 (0.070) | 6/240 | NT | 6.1% | coding (351/1293 nt) | secY1 | Sec family Type I general secretory pathway preprotein translocase SecY |
? | CP000730 | 2361978 = | 90 (1.090) | coding (328/1293 nt) | secY1 | Sec family Type I general secretory pathway preprotein translocase SecY | |||||
* | ? | CP000730 | 2388283 = | 75 (0.850) | 4 (0.050) | 3/224 | NT | 5.5% | intergenic (+18/+84) | USA300HOU_2247/USA300HOU_2248 | MFS family major facilitator transporter/hypothetical protein |
? | CP000730 | 2388362 = | 73 (0.950) | intergenic (+97/+5) | USA300HOU_2247/USA300HOU_2248 | MFS family major facilitator transporter/hypothetical protein | |||||
* | ? | CP000730 | 2533537 = | 104 (1.170) | 5 (0.060) | 4/240 | NT | 5.1% | intergenic (+33/+64) | murN/tcyC | FemAB family peptidoglycan biosynthesis protein/ABC superfamily ATP binding cassette transporter, ABC protein |
? | CP000730 | 2533595 = | 89 (1.080) | intergenic (+91/+6) | murN/tcyC | FemAB family peptidoglycan biosynthesis protein/ABC superfamily ATP binding cassette transporter, ABC protein | |||||
* | ? | CP000730 | = 2543400 | 83 (0.940) | 5 (0.060) | 5/240 | NT | 5.8% | intergenic (+5/‑373) | USA300HOU_2403/hlgC | hypothetical protein/gamma hemolysin component C |
? | CP000730 | = 2543418 | 86 (1.040) | intergenic (+23/‑355) | USA300HOU_2403/hlgC | hypothetical protein/gamma hemolysin component C | |||||
* | ? | CP000730 | 2661788 = | 88 (0.990) | 5 (0.060) | 5/226 | NT | 6.8% | intergenic (‑181/‑140) | USA300HOU_2514/USA300HOU_2515 | HAD superfamily hydrolase/ABC superfamily ATP binding cassette transporter, ABC protein |
? | CP000730 | 2661832 = | 60 (0.770) | intergenic (‑225/‑96) | USA300HOU_2514/USA300HOU_2515 | HAD superfamily hydrolase/ABC superfamily ATP binding cassette transporter, ABC protein | |||||
* | ? | CP000730 | = 2774115 | 85 (0.960) | 6 (0.070) | 4/244 | NT | 6.8% | coding (256/762 nt) | estA | tributyrin esterase EstA |
? | CP000730 | = 2774122 | 85 (1.010) | coding (249/762 nt) | estA | tributyrin esterase EstA |